FBLN1 and breast carcinoma: In Kaplan-Meier survival analyses for OS in TCGA-BRCA, the survival of breast cancer patients exhibiting high expression of PXDNL (p<0.0001) and SDC1 (p=0.0007) as well as low expression of FBLN1 (p=0.0025), FBLN5 (p=0.0029), LOXL1 (p=0.00037) and ADAMTS8 (p<0.0001) was significantly more unfavorable (Figure S1B).